Synopsys, Inc. Profile Avatar - Palmy Investing

Synopsys, Inc.

Synopsys, Inc. provides electronic design automation software products used to design and test integrated circuits. The company offers Fusion Design Platform that provides digital design implementation solutions; Verification Continuum Platform that prov…

Software - Infrastructure
US, Mountain View [HQ]

FA

Fundamental Analysis · Most Recent Quarter

It is important to understand the FA Algorithm and the criterias before valuing it as a top-tier resource.

Read Rationale
Framework:
Valuation 0% Bad
Profitability n.A. n.A.
Fin. Growth 83% Positive
Leverage & Liquidity 17% Weak
Per Share Metrics 67% Positive
Fin. Health n.A. n.A.
Fundamentals

Valuation

Metric Q1 Q2 Δ in %
EV/EBITDA -14.46 192.17 224.64
Graham Fair Price -16.85 44.82 53.91
PEG 23.14 -1.97 1.60
Price/Book -6.82 11.35 12.18
Price/Cash Flow -70.77 185.22 -633.75
Prices/Earnings 53.62 69.47 45.22
Price/Sales 13.19 55.76 49.26
Price/FCF -70.77 185.22 -633.75
Naive Interpretation member
01 - Valuation · Bad
Fundamentals

Profitability

Metric Q1 Q2 Δ in %
Gross Profit Margin -4.92 0.76 0.80
Operating Margin 4.93 0.23 0.22
ROA -37.64 0.03 0.04
ROE 0.07 0.04 -39.34
ROIC 0.05 0.04 -21.81
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q1 Q2 Δ in %
Debt QOQ -0.04 -0.03 -45.24
Dividends QOQ 0.00 0.00 0.00
EBIT QOQ -0.16 -0.07 55.21
EPS QOQ 0.28 -0.35 24.75
FCF QOQ -1.47 4.42 200.68
Revenue QOQ 0.03 -0.12 274.48
Naive Interpretation member
03 - Financial Growth · Positive
Fundamentals

Leverage & Liquidity

Metric Q1 Q2 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 104.64 97.76 -6.58
Days Sales Outstanding (DSO) 58.07 84.45 45.42
Inventory Turnover 0.86 0.92 7.04
Debt/Capitalization 0.02 0.01 -10.66
Quick Ratio 0.88 1.21 36.44
Naive Interpretation member
04 - Leverage & Liquidity · Weak
Fundamentals

Per Share Metrics

Metric Q1 Q2 Δ in %
Book Value 43.80 46.76 6.77
Cash 8.37 10.86 29.74
Capex -0.27 -0.25 5.41
Free Cash Flow -0.84 2.86 240.40
Revenue 10.83 9.52 -12.11
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q1 Q2 Δ in %
Current Ratio 1.29 1.86 43.95
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -1.25 -2.06 -64.24
Naive Interpretation Member
06 - Financial Health · Weak
End of SNPS's Analysis
CIK: 883241 CUSIP: 871607107 ISIN: US8716071076 LEI: - UEI: -
Secondary Listings